BioCentury | Feb 27, 2012
Company News

Edict Pharmaceuticals, Par Pharmaceutical deal

...$37.6 million in cash plus the repayment of certain debt (see BioCentury, May 30, 2011). Edict Pharmaceuticals Pvt. Ltd....
BioCentury | May 30, 2011
Company News

Edict Pharmaceuticals Pvt. Ltd., Par Pharmaceutical deal

...be accretive in 2013, is expected to close by year end. Terms were not disclosed. Edict Pharmaceuticals Pvt. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Feb 27, 2012
Company News

Edict Pharmaceuticals, Par Pharmaceutical deal

...$37.6 million in cash plus the repayment of certain debt (see BioCentury, May 30, 2011). Edict Pharmaceuticals Pvt. Ltd....
BioCentury | May 30, 2011
Company News

Edict Pharmaceuticals Pvt. Ltd., Par Pharmaceutical deal

...be accretive in 2013, is expected to close by year end. Terms were not disclosed. Edict Pharmaceuticals Pvt. Ltd....
Items per page:
1 - 2 of 2